Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Advances in epigenetic markers of dermatomyositis/polymyositis].

Yang YY, Zuo XX, Zhu HL, Liu SJ.

Beijing Da Xue Xue Bao Yi Xue Ban. 2019 Apr 18;51(2):374-377. Chinese.

2.

[Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].

Eymard B.

Presse Med. 2003 Oct 25;32(35):1656-67. Review. French.

PMID:
14631270
3.

Dermatomyositis And Polymyositis.

Cheeti A, Panginikkod S.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Feb 1.

4.

Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort.

Dobloug GC, Garen T, Brunborg C, Gran JT, Molberg Ø.

Semin Arthritis Rheum. 2015 Dec;45(3):301-8. doi: 10.1016/j.semarthrit.2015.06.005. Epub 2015 Jun 17.

PMID:
26190563
5.

The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis.

Lu X, Tang Q, Lindh M, Dastmalchi M, Alexanderson H, Popovic Silwerfeldt K, Agerberth B, Lundberg IE, Wick C.

J Autoimmun. 2017 Mar;78:46-56. doi: 10.1016/j.jaut.2016.12.003. Epub 2016 Dec 22.

PMID:
28012697
6.

Chemokines in idiopathic inflammatory myopathies.

De Paepe B, Creus KK, De Bleecker JL.

Front Biosci. 2008 Jan 1;13:2548-77. Review.

PMID:
17981734
7.

Using multi-omics methods to understand dermatomyositis/polymyositis.

Gao S, Luo H, Zhang H, Zuo X, Wang L, Zhu H.

Autoimmun Rev. 2017 Oct;16(10):1044-1048. doi: 10.1016/j.autrev.2017.07.021. Epub 2017 Aug 1. Review.

PMID:
28778709
8.

Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.

Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J, Paik JJ, Ahlawat S, Danoff SK, Lloyd TE, Mammen AL, Christopher-Stine L.

Ann Rheum Dis. 2017 Apr;76(4):681-687. doi: 10.1136/annrheumdis-2016-210198. Epub 2016 Sep 20.

9.

Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups.

Rothwell S, Cooper RG, Lundberg IE, Miller FW, Gregersen PK, Bowes J, Vencovsky J, Danko K, Limaye V, Selva-O'Callaghan A, Hanna MG, Machado PM, Pachman LM, Reed AM, Rider LG, Cobb J, Platt H, Molberg Ø, Benveniste O, Mathiesen P, Radstake T, Doria A, De Bleecker J, De Paepe B, Maurer B, Ollier WE, Padyukov L, O'Hanlon TP, Lee A, Amos CI, Gieger C, Meitinger T, Winkelmann J, Wedderburn LR, Chinoy H, Lamb JA; Myositis Genetics Consortium.

Ann Rheum Dis. 2016 Aug;75(8):1558-66. doi: 10.1136/annrheumdis-2015-208119. Epub 2015 Sep 11.

10.

Discovery of new biomarkers of idiopathic inflammatory myopathy.

Lu X, Peng Q, Wang G.

Clin Chim Acta. 2015 Apr 15;444:117-25. doi: 10.1016/j.cca.2015.02.007. Epub 2015 Feb 11. Review.

PMID:
25681646
11.

T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients.

Houtman M, Ekholm L, Hesselberg E, Chemin K, Malmström V, Reed AM, Lundberg IE, Padyukov L.

Arthritis Res Ther. 2018 Aug 29;20(1):188. doi: 10.1186/s13075-018-1688-7.

12.

Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.

Figarella-Branger D, Schleinitz N, Boutière-Albanèse B, Camoin L, Bardin N, Guis S, Pouget J, Cognet C, Pellissier JF, Dignat-George F.

J Rheumatol. 2006 Aug;33(8):1623-30.

PMID:
16881117
13.

cDNA microarrays reveal distinct gene expression clusters in idiopathic inflammatory myopathies.

Zhou X, Dimachkie MM, Xiong M, Tan FK, Arnett FC.

Med Sci Monit. 2004 Jul;10(7):BR191-7. Epub 2004 Jun 29.

PMID:
15232492
14.

Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.

Das L, Blumbergs PC, Manavis J, Limaye VS.

Appl Immunohistochem Mol Morphol. 2013 Dec;21(6):539-42. doi: 10.1097/PAI.0b013e31827d7f16.

PMID:
23343957
15.

Local expression of cytokines in idiopathic inflammatory myopathies.

Lepidi H, Frances V, Figarella-Branger D, Bartoli C, Machado-Baeta A, Pellissier JF.

Neuropathol Appl Neurobiol. 1998 Feb;24(1):73-9.

PMID:
9549732
16.

Idiopathic inflammatory myopathies.

van der Kooi AJ, de Visser M.

Handb Clin Neurol. 2014;119:495-512. doi: 10.1016/B978-0-7020-4086-3.00032-1. Review.

PMID:
24365315
17.

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis.

Hirai T, Ikeda K, Tsushima H, Fujishiro M, Hayakawa K, Yoshida Y, Morimoto S, Yamaji K, Takasaki Y, Takamori K, Tamura N, Sekigawa I.

Inflamm Regen. 2018 Jan 8;38:1. doi: 10.1186/s41232-017-0058-1. eCollection 2018.

18.

[The clinical significance of myositis-specific antibodies in polymyositis/dermatomyositis associated interstitial lung diseases].

Xie MM, Yan X, Li H, Ding JJ, Gui XH, Liu Y, Wang YS, Chen ZY, Cai HR.

Zhonghua Jie He He Hu Xi Za Zhi. 2018 Aug 12;41(8):616-621. doi: 10.3760/cma.j.issn.1001-0939.2018.08.009. Chinese.

PMID:
30138971
19.

Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.

Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ, van Engelen BG.

J Neurol. 2002 Jan;249(1):69-75.

PMID:
11954871
20.

Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies.

Macaione V, Aguennouz M, Mazzeo A, De Pasquale MG, Russo M, Toscano A, De Luca G, Di Giorgio RM, Vita G, Rodolico C.

Acta Neurol Scand. 2008 Jun;117(6):393-8. Epub 2007 Nov 14.

PMID:
18005224

Supplemental Content

Support Center